Article Details

Alembic partner's anti blood cancer drug gets US FDA nod

Retrieved on: 2021-02-09 17:41:10

Tags for this article:

Click the tags to see associated articles and topics

Alembic partner's anti blood cancer drug gets US FDA nod. View article details on hiswai:

Excerpt

Rhizen Pharmaceuticals AG, a clinical-stage, oncology-focused biopharma company, with 50% stake owned by Alembic Pharmaceuticals and the rest ...

Article found on: www.thehindu.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up